Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency

Conditions:   Parasitemia;   Clinical Malaria;   Immune Tolerance Interventions:   Drug: Dihydroartemisinin;   Drug: Piperaquine;   Drug: Primaquine;   Drug: Momordica Charantia Extract Sponsor:   Syamsudin Abdillah,Ph.D, Pharm D Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials